Weight Gain and Pregnancy Complications Rise After GLP-1 Discontinuation
Mass General Brigham
Discontinuing GLP-1 drugs early in pregnancy may raise risks of weight gain, diabetes, hypertension, and preterm delivery
Obesity
‘Skinny Fat’ Linked to Silent Artery Damage, Study Reveals
McMaster University
McMaster-led study shows hidden fat contributes to artery damage, regardless of body weight
American College of Physicians Issues Clinical Recommendations for Newer Pharmacological Treatments of Type 2 Diabetes
American College of Physicians
The updated guideline recommends adding an SGLT-2 inhibitor or GLP-1 agonist to metformin
Younger Women at Greater Risk of Rehospitalization after Heart Attacks
Swathi Kodaikal, MSc
Women’s health demands attention and intervention—more than ever before—to better understand the impact of various stressors
Obesity-Associated Biomarkers Found Elevated in Latinx Children
George Mason University
Levels of cardiometabolic biomarkers were higher in very young Latinx youth when compared to non-Latinx peers
Obesity at MS Diagnosis Linked to Higher Levels of Disability
BMJ-British Medical Journal
Reverting to a healthy weight may improve clinical outcome, suggest researchers
Electronic Health Record Tool Can Help Children Achieve Healthy Weight
University of Missouri
Kids enrolled in FitTastic study group had more favorable obesity trends
Scientists Redefine Obesity with Discovery of Two Major Subtypes
Van Andel Research Institute
The discovery may lead to more precise diagnostic and treatment options
Study Finds Undiagnosed Diabetes in US Less than Half of Current Estimates
Johns Hopkins University Bloomberg School of Public Health
Analysis suggests undiagnosed diabetes is more prevalent in older and obese adults and racial/ethnic minorities
Experts Call for a Unified Public Health Response to NAFLD and NASH Epidemic
American Gastroenterological Association
Patients with obesity or type 2 diabetes are at a higher risk of developing NAFLD and NASH